Apremilast treatment of atopic dermatitis and other chronic eczematous dermatoses Michael Abrouk, BS, Benjamin Farahnik, BS, Tian Hao Zhu, BS, Mio Nakamura,

Slides:

Advertisements

Similar presentations

Apremilast treatment of atopic dermatitis and other chronic eczematous dermatoses Michael Abrouk, BS, Benjamin Farahnik, BS, Tian Hao Zhu, BS, Mio Nakamura,

Advertisements

Clavi syphilitici–an unusual presentation of syphilis

Optimal time to provide skin cancer and photoprotection education to pediatric solid organ transplant recipients Lily Chen, BA, Feng Gao, MD, PhD, MPH,

Lauren Kwa, BA, Jonathan I. Silverberg, MD, PhD, MPH

A girl with a solitary red bulla

Apremilast in the treatment of moderate to severe hidradenitis suppurativa: A case series of 9 patients Patrizia Weber, MD, S. Morteza Seyed Jafari,

Volume 3, Issue 6, Pages (November 2017)

Yul W. Yang, MD, PhD, David J. DiCaudo, MD

Allyson Black, BS, Andrea Bershow, MD, Pamela S. Allen, MD, A

Baldness reversed by chemotherapy

Atopic dermatitis: Age and race do matter!

Megan Wood, MD, Tom Raisanen, MD, Ingrid Polcari, MD

Serum leptin and adiponectin levels in atopic dermatitis (AD) and their relation to disease severity Byeol Han, MD, Wen Hao Wu, PhD, Jung Min Bae, MD,

Miliarial gout: A rare clinical presentation

Elana Putterman, BS, Leslie Castelo-Soccio, MD, PhD

Shawn G. Kwatra, BS, Hong Liang Tey, MRCP (UK), Saba M

Surveillance and assessment of occupational dermatitis using Rhode Island workers' compensation data 1998 to 2002 Irwin B. Horwitz, PhD, Brian P. McCall,

The impact of secukinumab treatment on the prevalence of human papillomavirus in patients with psoriasis: A pilot study Hsien-Yi Chiu, MD, Tsen-Fang.

Pediatric teledermatology: Observations based on 429 consults

Clindamycin-induced Sweet syndrome

Ana Corcimaru, BS, Dean S. Morrell, MD, Craig N. Burkhart, MD

Sara A. Farber, BA, Sara Samimi, MD, Misha Rosenbach, MD

Zinc deficiency associated with necrolytic acral erythema

David T. Pompei, Pharm D, Kameron S. Rezzadeh, BS, Kate V

An enlarging, ulcerated scalp nodule

Khanh P. Thieu, BS, Harley A. Haynes, MD

Effect of appearance-based education compared with health-based education on sunscreen use and knowledge: A randomized controlled trial William Tuong,

Pharmacy costs of specialty medications for plaque psoriasis in the United States Eric J. Yang, BS, Kristen M. Beck, MD, Sahil Sekhon, MD, Tina Bhutani,

Smoking and risk of psoriasis: A nationwide cohort study

Pilot study of a skin cancer education curriculum for medical students

Kishore L. Jayakumar, BS, Sara S. Samimi, MD

Infliximab treatment for severe psoriasis in a patient with active hepatitis B virus infection Alberto Conde-Taboada, MD, Javier Pedraz Muñoz, MD, Lucía.

Duration of oral antibiotic therapy for the treatment of adult acne: A retrospective analysis investigating adherence to guideline recommendations and.

Reply to: “A note on normality”

A nonsteroidal alternative to impetiginized eczema in the emergency room Benjamin Stoff, MD, Jamie MacKelfresh, MD, Levi Fried, Cynthia Cohen, MD, Jack.

Successful use of a modified Goeckerman regimen in the treatment of generalized prurigo nodularis Eric Sorenson, AB, Ethan Levin, MD, John Koo, MD, Timothy.

A survey-based study on nail examinations at an American Academy of Dermatology free skin cancer screening Dayoung Ko, BS, Shari R. Lipner, MD, PhD

Increased serum levels of interleukin 33 in patients with atopic dermatitis Risa Tamagawa-Mineoka, MD, PhD, Yasutaro Okuzawa, MD, Koji Masuda, MD, PhD,

Loss of efficacy of secukinumab for psoriasis at 24 to 32 weeks

Infectious rash after riding elephants

Lip edema Journal of the American Academy of Dermatology

Topical tacrolimus for chronic actinic dermatitis

Allergic contact dermatitis caused by lanolin (wool) alcohol contained in an emollient in three postsurgical patients Josephine C. Nguyen, MD, Gregory.

Adherence to topical hydrocortisone 17-butyrate 0

Isotretinoin for high-grade or refractory epidermal growth factor receptor inhibitor-related acneiform papulopustular eruptions Herbert C. Chiang, MD,

Anjali Shroff, MD, Emma Guttman-Yassky, MD, PhD JAAD Case Reports

Pediatric psoriasis treated with apremilast

Stefan Tukaj, PhD, Detlef Zillikens, MD, Michael Kasperkiewicz, MD

Pityriasis rubra pilaris with polyarthritis treated with adalimumab

Seasonal patterns in alopecia areata, totalis, and universalis

Appearance of lentigines in psoriasis patients treated with apremilast

Medicaid acceptance among pediatric dermatologists

Penile calciphylaxis Journal of the American Academy of Dermatology

Christopher T. Cassetty, MD, Andrew F. Alexis, MD, MPH, Jerome L

Modification of the nail psoriasis severity index

Tofacitinib therapy for children with severe alopecia areata

Volume 3, Issue 4, Pages (July 2017)

Jose Fernández-Vozmediano, PhD, Jose Armario-Hita, MD

A simple algorithm for evaluating dermatologic disease in critically ill patients: A study based on retrospective review of medical intensive care unit.

Toshiyuki Yamamoto, MD, Satoru Nakamura, MD, Kiyoshi Nishioka, MD

Eyebrow transplantation: Alternative body sites as a donor source

Gaps in pain management in dermatology: A needs assessment from Canada

Numerous hyperpigmented macules of the oral mucosa

Brittany G. Craiglow, MD, Brett A. King, MD, PhD

Lisa A. Beck, MD, Sarbjit Saini, MD

Brian B. Johnson, MD, Lisa A. Beck, MD, S. Shahzad Mustafa, MD

Randomized study of topical tacrolimus ointment as possible treatment for resistant idiopathic pruritus ani Erwin Suys, MD Journal of the American Academy.

“Boot foot” with pseudomonas colonization

Stuart M. Goldsmith, MD, Armand B. Cognetta, MD

Volume 5, Issue 7, Pages (July 2019)

Presentation transcript:

Apremilast treatment of atopic dermatitis and other chronic eczematous dermatoses Michael Abrouk, BS, Benjamin Farahnik, BS, Tian Hao Zhu, BS, Mio Nakamura, MD, Rasnik Singh, BS, Kristina Lee, BS, Sara-Marian Lucking, MD, Jessin Blossom, MD, Wilson Liao, MD, John Koo, MD, Tina Bhutani, MD, Kanade Shinkai, MD, PhD, Tien Nguyen, MD Journal of the American Academy of Dermatology Volume 77, Issue 1, Pages 177-180 (July 2017) DOI: 10.1016/j.jaad.2017.03.020 Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions

Fig 1 Photo of patient's back. A, Before treatment with apremilast, back had generalized erythematous and lichenified plaques. B, After 10 weeks of treatment with apremilast, back had decreased erythema but persistent hyperpigmentation. Journal of the American Academy of Dermatology 2017 77, 177-180DOI: (10.1016/j.jaad.2017.03.020) Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions